Brady W. Dougan Buys 2,362 Shares of Humacyte, Inc. (NASDAQ:HUMA) Stock

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) Director Brady W. Dougan purchased 2,362 shares of the business’s stock in a transaction that occurred on Tuesday, June 4th. The shares were purchased at an average cost of $6.35 per share, with a total value of $14,998.70. Following the completion of the acquisition, the director now directly […]

Related Keywords

Piper Sandler ,Bradyw Dougan ,Capital Partners ,Nasdaq ,Vanguard Group Inc ,Advisor Group ,Cantor Fitzgerald ,Capstone Investment Advisors ,Humacyte Inc ,Humacyte Company Profile ,Rokos Capital Management ,Get Free Report ,Director Brady ,Investment Advisors ,Capital Management ,Humacyte Daily ,